LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia
References (16)
- et al.
In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
Neurosci. Lett.
(1997) - et al.
Metabotropic glutamate receptors and neurodegeneration
Prog. Brain Res.
(1998) - et al.
Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists LY354740 and DCG-IV
Eur. J. Pharmacol.
(1998) - et al.
Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795
Eur. J. Pharamacol.
(1999) - et al.
Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia
Neurosci. Lett.
(1998) - et al.
Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat
Neuroscience
(1997) - et al.
The metabotropic glutamate receptors: structure and functions
Neuropharmacology
(1995) - et al.
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamtate receptors
Neuropharmacology
(1997)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1999 Elsevier Science Ireland Ltd. All rights reserved.